Found: 10
Select item for more details and to access through your institution.
Post Hoc Analysis Evaluating the Impact of Antihyperglycemic Background Therapies on Attainment of A1C Targets Without Hypoglycemia in the ACHIEVE Control Pragmatic, Real-Life Study.
- Published in:
- Diabetes Spectrum, 2021, v. 34, n. 4, p. 407, doi. 10.2337/ds20-0079
- By:
- Publication type:
- Article
Initiative to Improve Evidence-Based Chronic Obstructive Pulmonary Disease Hospitalist Care Using a Novel On-Line Gamification Patient Simulation Tool: A Prospective Study.
- Published in:
- Healthcare (2227-9032), 2021, v. 9, n. 10, p. 1267, doi. 10.3390/healthcare9101267
- By:
- Publication type:
- Article
Switching between GLP‐1 receptor agonists in clinical practice: Expert consensus and practical guidance.
- Published in:
- International Journal of Clinical Practice, 2021, v. 75, n. 2, p. 1, doi. 10.1111/ijcp.13731
- By:
- Publication type:
- Article
Insulin glargine 300 U/mL versus first-generation basal insulin analogues in insulin-naïve adults with type 2 diabetes: 12-month outcomes of ACHIEVE Control, a prospective, randomized, pragmatic real-life clinical trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 11, p. 1995, doi. 10.1111/dom.14116
- By:
- Publication type:
- Article
How Effective Is the Fixed-Ratio Combination of Insulin Degludec and Liraglutide (IDegLira) in Different Patient Populations, and When Should It Be Used in Clinical Practice?
- Published in:
- Clinical Diabetes, 2020, v. 38, n. 4, p. 339, doi. 10.2337/cd20-0014
- By:
- Publication type:
- Article
The Pleiotropic Effects of Sodium–Glucose Cotransporter-2 Inhibitors: Beyond the Glycemic Benefit.
- Published in:
- Diabetes Therapy, 2019, v. 10, n. 5, p. 1771, doi. 10.1007/s13300-019-00686-z
- By:
- Publication type:
- Article
1087-P: A Randomized Pragmatic Real-World Clinical Trial Comparing Insulin Glargine 300 U/mL (Gla-300) with Standard of Care First-Generation Basal Insulins (SoC-BIs) in Insulin-Naïve Patients with Type 2 Diabetes: Twelve-Month Analysis of the ACHIEVE Control Study
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1087-P
- By:
- Publication type:
- Article
Insulin Initiation and Titration in Patients With Type 2 Diabetes.
- Published in:
- Diabetes Spectrum, 2019, v. 32, n. 2, p. 104, doi. 10.2337/ds18-0005
- By:
- Publication type:
- Article
Improved Treatment Engagement Among Patients with Diabetes Treated with Insulin Glargine 300 U/mL Who Participated in the COACH Support Program.
- Published in:
- Diabetes Therapy, 2018, v. 9, n. 5, p. 2143, doi. 10.1007/s13300-018-0501-6
- By:
- Publication type:
- Article
iGlarLixi: A New Once-Daily Fixed-Ratio Combination of Basal Insulin Glargine and Lixisenatide for the Management of Type 2 Diabetes.
- Published in:
- Diabetes Spectrum, 2018, v. 31, n. 2, p. 145, doi. 10.2337/ds17-0014
- By:
- Publication type:
- Article